<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39187787</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Monitoring the VDPV2 outbreak in Egypt during 2020-2021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus.</ArticleTitle><Pagination><StartPage>866</StartPage><MedlinePgn>866</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">866</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09731-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Poliovirus is a highly infectious enterovirus (EV) that primarily affects children and can lead to lifelong paralysis or even death. Vaccine-derived polioviruses (VDPVs) are a great threat since they are derived from the attenuated virus in the Oral Poliovirus Vaccine (OPV) and can mutate to a more virulent form. The purpose of this study was to identify VDPV serotype 2 through the year 2020-2021 via surveillance of sewage samples collected from different localities and governorates in Egypt and stool specimens from Acute Flaccid Paralysis (AFP) cases. Both were collected through the national poliovirus surveillance system and according to the guidelines recommended by the WHO.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 1266 sewage samples and 3241 stool samples from January 2020 to December 2021 were investigated in the lab according to World Health Organization (WHO) protocol for the presence of Polioviruses by cell culture, molecular identification of positive isolates on L20B cell line was carried out using real-time polymerase chain reactions (RT-PCR). Any positive isolates for Poliovirus type 2 and isolates suspected of Vaccine Derived Poliovirus Type 1 and type 3 screened by (VDPV1) or Vaccine Poliovirus Type 3 (VDPV3) assay in RT-PCR were referred for VP1 genetic sequencing.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The outbreak was caused by circulating VDPV2 (cVDPV2) strains started in January 2021. By the end of February 2021, a total of 11 cVDPV2s were detected in sewage samples from six governorates confirming the outbreak situation. One additional cVDPV2 was detected later in the sewage sample from Qena (June 2021). The first and only re-emergence of VDPV2 in stool samples during the outbreak was in contact with Luxor in June 2021. By November 2021, a total of 80 VDPVs were detected. The Egyptian Ministry of Health and Population (MOHP), in collaboration with the WHO, responded quickly by launching two massive vaccination campaigns targeting children under the age of five. Additionally, surveillance systems were strengthened to detect new cases and prevent further spread of the virus.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The continued threat of poliovirus and VDPVs requires ongoing efforts to prevent their emergence and spread. Strategies such as improving immunization coverage, using genetically stable vaccines, and establishing surveillance systems are critical to achieving global eradication of poliovirus and efficient monitoring of VDPVs outbreaks.</AbstractText><CopyrightInformation>Â© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shabana</LastName><ForeName>Menna R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>WHO Regional Reference lab for Diagnosis of Poliovirus and Enteroviruses, VACSERA Dokki, Giza, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaghloul</LastName><ForeName>Amira Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>WHO Regional Reference lab for Diagnosis of Poliovirus and Enteroviruses, VACSERA Dokki, Giza, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Shaarawy</LastName><ForeName>Tamer H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>WHO Regional Reference lab for Diagnosis of Poliovirus and Enteroviruses, VACSERA Dokki, Giza, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elleboudy</LastName><ForeName>Nooran S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Organization of African Union, Ain Shams University, St. Abbassia, Cairo, 11566, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboshanab</LastName><ForeName>Khaled M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-7608-850X</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Organization of African Union, Ain Shams University, St. Abbassia, Cairo, 11566, Egypt. aboshanab2012@pharma.asu.edu.eg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012722">Sewage</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004534" MajorTopicYN="N" Type="Geographic">Egypt</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012722" MajorTopicYN="Y">Sewage</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="Y">Environmental Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="Y">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="Y">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Environmental surveillance</Keyword><Keyword MajorTopicYN="N">Oral poliovirus vaccine</Keyword><Keyword MajorTopicYN="N">Sewage</Keyword><Keyword MajorTopicYN="N">Stool</Keyword><Keyword MajorTopicYN="N">Vaccine-derived polioviruses (VDPVs)</Keyword><Keyword MajorTopicYN="N">World Health Organization</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39187787</ArticleId><ArticleId IdType="pmc">PMC11348703</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09731-0</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09731-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Simmonds P, Gorbalenya AE, Harvala H, Hovi T, Knowles NJ, Lindberg AM, et al. Recommendations for the nomenclature of enteroviruses and rhinoviruses. Arch Virol. 2020;165(3):793â7. 10.1007/s00705-019-04520-6. 10.1007/s00705-019-04520-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-019-04520-6</ArticleId><ArticleId IdType="pmc">PMC7024059</ArticleId><ArticleId IdType="pubmed">31980941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Pallansch MA, Cochi SL, Thompson KM. Updated characterization of Poliovirus Transmission in Pakistan and Afghanistan and the impacts of different outbreak response Vaccine options. J Infect Dis. 2021;224(9):1529â38. 10.1093/infdis/jiab160. 10.1093/infdis/jiab160</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab160</ArticleId><ArticleId IdType="pmc">PMC8083227</ArticleId><ArticleId IdType="pubmed">33885734</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay AS, Singh H, Fournier-Caruana J, Modlin JF, Wenger J, Partridge J, et al. Facility-Associated Release of polioviruses into communities-risks for the Posteradication era. Emerg Infect Dis. 2019;25(7):1363â9. 10.3201/eid2507.181703. 10.3201/eid2507.181703</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2507.181703</ArticleId><ArticleId IdType="pmc">PMC6590745</ArticleId><ArticleId IdType="pubmed">31082331</ArticleId></ArticleIdList></Reference><Reference><Citation>Famulare M, Chang S, Iber J, Zhao K, Adeniji JA, Bukbuk D, et al. Sabin Vaccine Reversion in the field: a comprehensive analysis of Sabin-Like Poliovirus isolates in Nigeria. J Virol. 2015;90(1):317â31. 10.1128/JVI.01532-15. 10.1128/JVI.01532-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01532-15</ArticleId><ArticleId IdType="pmc">PMC4702576</ArticleId><ArticleId IdType="pubmed">26468545</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XM, Zhang ZJ, Wang HH, Liu F, Zhang LW, Chu P, et al. Immunogenicity and safety of a booster dose of inactivated polio vaccine. Zhonghua Yu Fang Yi Xue Za Zhi. 2013;47(10):905â9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24378129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming LC, Hussain Z, Yeoh SF, Koh D, Lee KS. Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication. Global Health. 2020;16(1):63. 10.1186/s12992-020-00594-z. 10.1186/s12992-020-00594-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-020-00594-z</ArticleId><ArticleId IdType="pmc">PMC7364572</ArticleId><ArticleId IdType="pubmed">32677974</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283â93. 10.1093/infdis/jiu295. 10.1093/infdis/jiu295</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu295</ArticleId><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>GPEI: Global Poli Eradication initiative. (2016): https://polioeradication.org/polio-today/polio-prevention/the-virus/vaccine-derived-polio-viruses/ (accessed on 13 September 2023).</Citation></Reference><Reference><Citation>Darwar R, Biya O, Greene SA, Jorba J, Al Safadi M, Franka R, et al. Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020. Vaccine. 2023;41(1):A25â34. 10.1016/j.vaccine.2023.02.060. 10.1016/j.vaccine.2023.02.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.060</ArticleId><ArticleId IdType="pmc">PMC10354706</ArticleId><ArticleId IdType="pubmed">36863925</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC (Centers for Disease Control and Prevention.). https://stacks.cdc.gov/view/cdc/126383 (accessed on 13 September 2023).</Citation></Reference><Reference><Citation>Patel JC, Diop OM, Gardner T, Chavan S, Jorba J, Wassilak SGF, et al. MMWR Morb Mortal Wkly Rep. 2019;68(13):312â8. 10.15585/mmwr.mm6813a4. Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2017â2018.10.15585/mmwr.mm6813a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6813a4</ArticleId><ArticleId IdType="pmc">PMC6611474</ArticleId><ArticleId IdType="pubmed">30946737</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamed SM, Sakr MM, El-Housseiny GS, Wasfi R, Aboshanab KM. State of the art in epitope mapping and opportunities in COVID-19. Future Sci OA. 2023;16(3â06):FSO832. 10.2144/fsoa-2022-0048. 10.2144/fsoa-2022-0048</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/fsoa-2022-0048</ArticleId><ArticleId IdType="pmc">PMC9987558</ArticleId><ArticleId IdType="pubmed">36897962</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhry R, Shukla A, Datta T, Dhole TN. Rapid detection of sewage sample polioviruses by integrated cell culture polymerase chain reaction. Arch Environ Occup Health. 2005;60:223â8. 10.3200/aeoh.60.4.223-228. 10.3200/aeoh.60.4.223-228</Citation><ArticleIdList><ArticleId IdType="doi">10.3200/aeoh.60.4.223-228</ArticleId><ArticleId IdType="pubmed">17214293</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Ent MMVX, Swift RD, Anaokar S, Hegg LA, Eggers R, Cochi SL. Contribution of global Polio Eradication Initiative-Funded Personnel to the strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic Plan. J Infect Dis. 2017;216(1):S244â9. 10.1093/infdis/jiw567. 10.1093/infdis/jiw567</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw567</ArticleId><ArticleId IdType="pmc">PMC5853847</ArticleId><ArticleId IdType="pubmed">28838165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerloff N, Sun H, Mandelbaum M, Maher C, Nix WA, Zaidi S, et al. Diagnostic Assay Development for Poliovirus Eradication. J Clin Microbiol. 2018;56(2):e01624â17. 10.1128/JCM.01624-17. 10.1128/JCM.01624-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01624-17</ArticleId><ArticleId IdType="pmc">PMC5786708</ArticleId><ArticleId IdType="pubmed">29212703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesfaye B, Sowe A, Kisangau N, Ogange J, Ntoburi S, Nekar I, et al. An epidemiological analysis of Acute Flaccid paralysis (AFP) surveillance in Kenya, 2016 to 2018. BMC Infect Dis. 2020;20(1):611. 10.1186/s12879-020-05319-6. 10.1186/s12879-020-05319-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05319-6</ArticleId><ArticleId IdType="pmc">PMC7437168</ArticleId><ArticleId IdType="pubmed">32811467</ArticleId></ArticleIdList></Reference><Reference><Citation>Polio Eradication Strategy 2022â2026: Delivering on a Promise. https://polioeradication.org/wp-content/uploads/2022/06/Polio-Eradication-Strategy-2022-2026-Delivering-on-a-Promise.pdf</Citation></Reference><Reference><Citation>Abd-Elmaksoud S, Naranjo JE, Gerba CP. Assessment of a portable handheld UV light device for the disinfection of viruses and bacteria in water. Food Environ Virol. 2013;5(2):87â90. 10.1007/s12560-013-9103-7. 10.1007/s12560-013-9103-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12560-013-9103-7</ArticleId><ArticleId IdType="pubmed">23412725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaidez C, Ibarra-RodrÃ­guez JR, Valdez-Torres JB, Soto M, Gerba CP, Castro-Del Campo N. Point-of-use unit based on gravity Ultrafiltration removes Waterborne gastrointestinal pathogens from untreated water sources in Rural communities. Wilderness Environ Med. 2016;27(3):379â85. 10.1016/j.wem.2016.05.006. 10.1016/j.wem.2016.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wem.2016.05.006</ArticleId><ArticleId IdType="pubmed">27591708</ArticleId></ArticleIdList></Reference><Reference><Citation>Achak M, Alaoui Bakri S, Chhiti Y, Mâhamdi Alaoui FE, Barka N, Boumya W. SARS-CoV-2 in hospital wastewater during outbreak of COVID-19: a review on detection, survival and disinfection technologies. Sci Total Environ. 2021;761:143192. 10.1016/j.scitotenv.2020.143192. 10.1016/j.scitotenv.2020.143192</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.143192</ArticleId><ArticleId IdType="pmc">PMC7585361</ArticleId><ArticleId IdType="pubmed">33153744</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014; 210 Suppl 1:S283-93. 10.1093/infdis/jiu295. PMID: 25316847.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Estivariz CF, Kovacs SD, Mach O. Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks. Vaccine. 2023;41(1):A113â21. 10.1016/j.vaccine.2022.03.027. 10.1016/j.vaccine.2022.03.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.03.027</ArticleId><ArticleId IdType="pmc">PMC10389290</ArticleId><ArticleId IdType="pubmed">35365341</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugieda M, Adachi S, Inayoshi M, Masuda T, Tsubota M, Mano H, et al. Intrafamilial transmission of a Sabin 1-related poliovirus in Shizuoka Prefecture, Japan. Jpn J Infect Dis. 2006;59(4):277â8. PMID: 16936354. 10.7883/yoken.JJID.2006.277</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2006.277</ArticleId><ArticleId IdType="pubmed">16936354</ArticleId></ArticleIdList></Reference><Reference><Citation>Faye M, KÃ©bÃ© O, Diop B, Ndiaye N, Dosseh A, Sam A, et al. Importation and circulation of vaccine-derived Poliovirus Serotype 2, Senegal, 2020â2021. Emerg Infect Dis. 2022;28(10):2027â34. 10.3201/eid2810.220847. 10.3201/eid2810.220847</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2810.220847</ArticleId><ArticleId IdType="pmc">PMC9514370</ArticleId><ArticleId IdType="pubmed">36148906</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Qassimi MA, Al Amad M, Anam L, Almoayed K, Al-Dar A, Ezzadeen F. Circulating vaccine derived Polio virus type 1 outbreak, Saadah governorate, Yemen, 2020. BMC Infect Dis. 2022;22(1):414. 10.1186/s12879-022-07397-0. 10.1186/s12879-022-07397-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07397-0</ArticleId><ArticleId IdType="pmc">PMC9052627</ArticleId><ArticleId IdType="pubmed">35488227</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Qassimi MA, Al Amad M, Al-Dar A, Al Sakaf E, Al Hadad A, Rajaâa YA. Circulating vaccine derived Polio virus type 2 outbreak and response in Yemen, 2021â2022, a retrospective descriptive analysis. BMC Infect Dis. 2024;24(1):321. 10.1186/s12879-024-09215-1. 10.1186/s12879-024-09215-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09215-1</ArticleId><ArticleId IdType="pmc">PMC10943856</ArticleId><ArticleId IdType="pubmed">38491425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>